| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1614211 | F | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | 36,499 | ALA1201862 | assay format | PubChem BioAssays | ||
| 2. | ALA1794345 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 170,142 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 3. | ALA1794401 | F | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | 91,504 | ALA1201862 | assay format | PubChem BioAssays | ||
| 4. | ALA1794560 | F | PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) | 447 | ALA1201862 | assay format | PubChem BioAssays | ||
| 5. | ALA1794580 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 130,890 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 6. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | ALA1201862 | assay format | PubChem BioAssays | ||
| 7. | ALA2354254 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) | 153,867 | ALA1201862 | assay format | PubChem BioAssays | ||
| 8. | ALA3760519 | F | Antiviral activity against Hepatitis B virus in human HepAD38 cells assessed as inhibition of extracellular viral replication at 10 uM incubated for 2 days followed by 3 day incubation with fresh medium containing compound for 72 hrs by qRT-PCR analysis | Hepatitis B virus | 31 | ALA3758143 | organism-based format | Scientific Literature | |
| 9. | ALA3760520 | F | Antiviral activity against Hepatitis B virus in human HepAD38 cells assessed as inhibition of extracellular viral replication incubated for 2 days followed by 3 day incubation with fresh medium containing compound for 72 hrs by qRT-PCR analysis | Hepatitis B virus | 7 | ALA3758143 | organism-based format | Scientific Literature | |
| 10. | ALA3760521 | A | Cytotoxicity against human HepAD38 cells after 7 days by MTT assay | Homo sapiens | 7 | ALA3758143 | cell-based format | Scientific Literature | |
| 11. | ALA3760522 | T | Selectivity index, ratio of CC50 for human HepAD38 cells to EC50 for Hepatitis B virus | 7 | ALA3758143 | cell-based format | Scientific Literature | ||
| 12. | ALA3790647 | F | Antiviral activity against HIV2 ROD infected in human MT4 cells assessed as cell viability after 4 days by MTT assay | Human immunodeficiency virus 2 | 21 | ALA3784991 | organism-based format | Scientific Literature | |
| 13. | ALA3790648 | T | Selectivity index, ratio of CC50 for mock infected human MT4 cells to EC50 for HIV2 ROD infected in human MT4 cells | 21 | ALA3784991 | cell-based format | Scientific Literature | ||
| 14. | ALA3788085 | F | Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as cell viability after 4 days by MTT assay | Human immunodeficiency virus 1 | 25 | ALA3784991 | organism-based format | Scientific Literature | |
| 15. | ALA3788087 | A | Cytotoxicity against mock infected human MT4 cells after 4 days by MTT assay | Homo sapiens | 25 | ALA3784991 | cell-based format | Scientific Literature | |
| 16. | ALA3788088 | T | Selectivity index, ratio of CC50 for mock infected human MT4 cells to EC50 for HIV1 3B infected in human MT4 cells | 25 | ALA3784991 | cell-based format | Scientific Literature | ||
| 17. | ALA3802508 | F | Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as reduction of virus-induced cytopathic effect after 5 days by MTT assay | Human immunodeficiency virus 1 | 19 | ALA3797100 | organism-based format | Scientific Literature | |
| 18. | ALA3802510 | A | Cytotoxicity against human MT4 cells after 5 days MTT assay | Homo sapiens | 19 | ALA3797100 | cell-based format | Scientific Literature | |
| 19. | ALA3802511 | T | Selectivity index, ratio of CC50 for human MT4 cells to EC50 for HIV-1 3B infected in human MT4 cells | 19 | ALA3797100 | cell-based format | Scientific Literature | ||
| 20. | ALA3802512 | B | Inhibition of HIV1 wild type reverse transcriptase p66/p51 using poly(rA) template and measured after 40 mins by picogreen based spectrofluorometry | Human immunodeficiency virus 1 | 19 | ALA3797100 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!